Vitamin C nasal drops for removing latent germs

By using nasal drops composed of vitamin C and other auxiliary ingredients, the side effects and insufficient safety of traditional nasal drops are solved, and effective removal of latent nasal bacteria and healthy maintenance of nasal mucosa is achieved.

CN119770426AInactive Publication Date: 2025-04-08谢新刚
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CN202510152719.5
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2025-02-12
Publication Date
2025-04-08
Estimated Expiration
Not applicable · inactive patent

AI Technical Summary

Technical Problem

Traditional antibiotics and hormone nasal drops have many side effects during use, and are not safe enough to effectively remove latent bacteria in the nasal cavity.

Method used

Nasal drops with vitamin C as the main ingredient are combined with osmotic pressure regulators, antibacterial agents, moisturizing agents, stabilizers, preservatives and pH regulators to form a vitamin C nasal drop that removes latent bacteria.

Benefits of technology

Through the antioxidant, anti-inflammatory and pro-mucosal repair effects of vitamin C, it significantly reduces nasal mucosal inflammation, improves nasal ventilation function, effectively relieves nasal congestion, runny nose, sneezing and other symptoms, enhances the immunity of the nasal mucosa, and has no obvious side effects. It is suitable for special groups such as children, pregnant women and the elderly.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN119770426A_ABST
    Figure CN119770426A_ABST
Patent Text Reader

Abstract

The invention relates to the field of nasal drops, and particularly discloses a vitamin C nasal drop for removing latent bacteria. According to the vitamin C nasal drop, the vitamin C, the osmotic pressure regulator, the antibacterial agent, the humectant, the stabilizer, the preservative, the pH regulator and the purified water solvent are used for forming the vitamin C nasal drop, and the vitamin C has various physiological functions of resisting oxidation, enhancing immunity, resisting inflammation, promoting mucous membrane repair and the like and can be used for comprehensively treating nasal diseases from multiple aspects; the nasal drops can obviously reduce nasal mucosa inflammation of a patient, help mucosa epithelial cells to recover completeness, obviously improve the ventilation function of the nasal cavity, effectively relieve symptoms such as nasal obstruction, running nose and sneezing, stimulate metabolism of the nasal cavity, acidolysis of infected mucosa can be achieved, germs can be eliminated, and the nasal drops are safe and reliable. Waste nasal drops and infected mucous membranes are discharged together through secretions such as snot, germs in the nasal cavity are discharged, and a safe nasal cavity environment with few germs is formed.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The invention belongs to the technical field of nasal drops, and in particular relates to vitamin C nasal drops for removing latent pathogens. Background Art

[0002] With the accelerated pace of modern life and the complex changes in environmental factors, the incidence of nasal diseases such as rhinitis and sinusitis has been increasing year by year. These diseases not only bring physical discomfort to patients, such as nasal congestion, runny nose, sneezing, etc., but may also cause a series of complications such as headaches, dizziness, memory loss, etc., seriously affecting the quality of life and work efficiency of patients. At present, there are many kinds of drugs on the market for the treatment of nasal diseases, but most of them have certain limitations, such as antibiotics are prone to drug resistance, and long-term use of hormone drugs may cause side effects. Therefore, the development of a safe, effective and low-side effect drug for the treatment of nasal diseases has important clinical significance and social value.

[0003] Vitamin C, as a common nutrient, has a variety of physiological functions that are beneficial to the human body. It is a powerful antioxidant that can remove free radicals in the body and enhance the body's immunity; at the same time, vitamin C is also involved in the synthesis of collagen, which helps to maintain the integrity of the nasal mucosa and promote the repair of damaged mucosa. In addition, vitamin C also has a certain anti-inflammatory effect and can reduce the inflammatory response of the nasal mucosa. Based on the above theoretical basis, the present invention proposes a nasal drop with vitamin C as the main ingredient, aiming to provide a new, safer and more effective solution for the treatment of nasal diseases. Summary of the invention

[0004] In order to overcome the deficiencies of the prior art, the purpose of the present invention is to provide a vitamin C nasal drop for removing latent pathogens, so as to solve the problem that traditional antibiotic and hormone nasal drops have many side effects and insufficient safety during use.

[0005] To achieve the above object, the present invention provides the following technical solutions:

[0006] A vitamin C nasal drop for removing latent pathogens, comprising the following components:

[0007] Vitamin C, mass concentration is 20% to 40%;

[0008] Osmotic pressure regulator, mass concentration is 0.5% to 5%;

[0009] Antimicrobial agent, mass concentration is 0.01% to 0.05%;

[0010] Moisturizer, mass concentration is 1% to 3%;

[0011] Stabilizer, mass concentration is 0.01% to 0.5%;

[0012] Preservatives, mass concentration is 0.01% to 0.5%;

[0013] pH adjusters;

[0014] Purified water solvent.

[0015] Preferably, the mass concentration of the vitamin C is 25% to 33%.

[0016] Preferably, the mass concentration of the osmotic pressure regulator is 1% to 3%, and the osmotic pressure regulator includes sodium chloride and glucose.

[0017] Preferably, the antimicrobial agent comprises benzalkonium chloride.

[0018] Preferably, the humectant comprises glycerin.

[0019] Preferably, the mass concentration of the stabilizer is 0.05% to 0.2%, and the stabilizer includes disodium EDTA.

[0020] Preferably, the mass concentration of the preservative is 0.05% to 0.2%, and the preservative includes benzoic acid, sorbic acid and parabens.

[0021] Preferably, the pH adjuster includes phosphate buffer and acetate buffer, and the added amount is an amount to adjust the pH value of the nasal drop system to 5.5-7.5.

[0022] Preferably, the preparation method of vitamin C nasal drops is as follows:

[0023] Weigh and take the corresponding mass of vitamin C, osmotic pressure regulator, antibacterial agent, moisturizer, stabilizer, preservative, pH regulator and purified water solvent according to the configuration requirements;

[0024] Dissolve vitamin C in a portion of purified water solvent and stir until the vitamin C is completely dissolved to obtain a vitamin C solution;

[0025] Adding an osmotic pressure regulator, an antibacterial agent, a moisturizer, a stabilizer, a preservative and a pH regulator to the vitamin C solution in sequence, stirring until completely dissolved, to obtain a nasal drop concentrate;

[0026] Add the remaining purified water solvent to the nasal drops concentrate, and stir evenly to obtain the nasal drops;

[0027] The nasal drops were filtered through a 0.22 μm microporous filter membrane to obtain sterile nasal drops;

[0028] The sterile nasal drops are filled into a sterile nasal drops bottle, and sealed to obtain a finished nasal drops product.

[0029] Preferably, the stirring is performed until the vitamin C is completely dissolved so that the temperature is 40°C to 60°C.

[0030] Compared with the prior art, the present invention has the following beneficial effects:

[0031] The present invention uses vitamin C, osmotic pressure regulator, antibacterial agent, moisturizer, stabilizer, preservative, pH regulator and purified water solvent to form vitamin C nasal drops. Vitamin C has multiple physiological functions such as anti-oxidation, enhancing immunity, anti-inflammatory and promoting mucosal repair, and can perform comprehensive treatment on nasal diseases from multiple aspects, can significantly reduce the inflammation of the nasal mucosa of the patient, help restore the integrity of mucosal epithelial cells, significantly improve the nasal ventilation function, and effectively alleviate the symptoms of nasal congestion, runny nose, sneezing and the like. The use of the nasal drops can stimulate the metabolism of the nasal cavity, and the nasal drops can acidify the infected mucosa to eliminate bacteria, discharge the waste liquid of the nasal drops and the infected mucosa together through secretions such as nasal mucus, discharge the bacteria inside the nasal cavity, and form a nasal cavity environment with few bacteria and safety. In addition, the antibacterial performance of the nasal drops is enhanced by the antibacterial agent, and at a normal dosage, no obvious side effects are produced, and no irritation and damage are caused to the nasal mucosa, and the nasal drops can be used for a long time, and are particularly suitable for special groups such as children, pregnant women and the elderly, and have high safety in use. BRIEF DESCRIPTION OF THE DRAWINGS

[0032] Figure 1 This is a diagram showing the components of a vitamin C nasal drop for removing latent pathogens disclosed in the present invention;

[0033] Figure 2 The present invention discloses a method for preparing vitamin C nasal drops for removing latent pathogens. DETAILED DESCRIPTION

[0034] The following will be combined with the drawings in the embodiments of the present invention to clearly and completely describe the technical solutions in the embodiments of the present invention. Obviously, the described embodiments are only part of the embodiments of the present invention, not all of the embodiments. Based on the embodiments of the present invention, all other embodiments obtained by ordinary technicians in this field without creative work are within the scope of protection of the present invention.

[0035] Embodiment 1:

[0036] See also Figure 1 As shown, a vitamin C nasal drop for removing latent pathogens comprises the following components: vitamin C, with a mass concentration of 20% to 40%; an osmotic pressure regulator, with a mass concentration of 0.5% to 5%; an antibacterial agent, with a mass concentration of 0.01% to 0.05%; a moisturizer, with a mass concentration of 1% to 3%; a stabilizer, with a mass concentration of 0.01% to 0.5%; a preservative, with a mass concentration of 0.01% to 0.5%; a pH regulator; and a purified water solvent.

[0037] As can be seen from the above, vitamin C nasal drops are composed of vitamin C, osmotic pressure regulators, antibacterial agents, moisturizers, stabilizers, preservatives, pH regulators and purified water solvents. Vitamin C has multiple physiological functions such as anti-oxidation, enhancing immunity, anti-inflammatory and promoting mucosal repair. It can comprehensively treat nasal diseases from multiple aspects, can significantly reduce the patient's nasal mucosal inflammation, help restore the integrity of mucosal epithelial cells, significantly improve nasal ventilation function, and effectively relieve symptoms such as nasal congestion, runny nose, sneezing, etc. The use of this nasal drop can stimulate the metabolism of the nasal cavity, and the nasal drop can acidify the infected mucosa and eliminate bacteria. The nasal drop waste liquid and infected mucosa are discharged together through secretions such as nasal mucus, and the bacteria inside the nasal cavity are discharged to form a nasal environment with few bacteria and safety. In addition, the antibacterial performance of the nasal drops is enhanced by antibacterial agents. At normal dosages, no obvious side effects will be produced, and no irritation or damage will be caused to the nasal mucosa. It can be used for a long time, and is especially suitable for special populations such as children, pregnant women and the elderly, and has a high safety of use.

[0038] Vitamin C is the core ingredient of this formula, and its content is determined based on a comprehensive consideration of the absorption capacity of the nasal mucosa and the therapeutic effect. When the concentration of vitamin C is within the above range, an effective drug concentration gradient can be formed on the surface of the nasal mucosa, stimulating nasal metabolism with a higher concentration of vitamin C. At the same time, the vitamin C solution can acidify the infected mucosa and dissolve the waste liquid and discharge it from the nasal cavity in the form of nasal mucus, thereby reducing the number of pathogens inside the nasal cavity and thereby improving the healing effect of nasal diseases. Different from traditional bactericidal and antibacterial methods, it can effectively avoid drug resistance problems. Even if too much vitamin C is absorbed by the human body, it will be excreted from the body through urine. Compared with oral vitamin C, the topical treatment effect is more prominent, which can significantly enhance the immunity of the nasal mucosa, strengthen the natural defense function of the respiratory tract, relieve nasal dryness and discomfort, and improve respiratory health.

[0039] Antibacterial agents can increase the bactericidal effect of the nasal drop system and effectively remove latent pathogens inside the nasal cavity. Moisturizers can keep the nasal cavity moist, prevent the nasal cavity from drying out, and effectively maintain the protective effect of the nasal mucosa. Stabilizers can prevent the oxidation of vitamin C in the nasal drops. Preservatives can prevent microbial contamination of the nasal drops. Osmotic pressure regulators make the osmotic pressure of the nasal drops match the physiological osmotic pressure of the human nasal mucosa, reduce the irritation of the nasal drops to the nasal mucosa, and improve the patient's comfort. pH regulators are used to adjust the pH value of the nasal drops to close to the normal pH value of the human nasal mucosa, which is beneficial to the stability of vitamin C and the absorption of drugs by the nasal mucosa.

[0040] Embodiment 2:

[0041] See also Figure 1As shown, a vitamin C nasal drop for removing latent pathogens comprises the following components: vitamin C, with a mass concentration of 20% to 40%; an osmotic pressure regulator, with a mass concentration of 0.5% to 5%; an antibacterial agent, with a mass concentration of 0.01% to 0.05%; a moisturizer, with a mass concentration of 1% to 3%; a stabilizer, with a mass concentration of 0.01% to 0.5%; a preservative, with a mass concentration of 0.01% to 0.5%; a pH regulator; and a purified water solvent.

[0042] As can be seen from the above, vitamin C nasal drops are composed of vitamin C, osmotic pressure regulators, antibacterial agents, moisturizers, stabilizers, preservatives, pH regulators and purified water solvents. Vitamin C has multiple physiological functions such as anti-oxidation, enhancing immunity, anti-inflammatory and promoting mucosal repair. It can comprehensively treat nasal diseases from multiple aspects, can significantly reduce the patient's nasal mucosal inflammation, help restore the integrity of mucosal epithelial cells, significantly improve nasal ventilation function, and effectively relieve symptoms such as nasal congestion, runny nose, sneezing, etc. The use of this nasal drop can stimulate the metabolism of the nasal cavity, and the nasal drop can acidify the infected mucosa and eliminate bacteria. The nasal drop waste liquid and infected mucosa are discharged together through secretions such as nasal mucus, and the bacteria inside the nasal cavity are discharged to form a nasal environment with few bacteria and safety. In addition, the antibacterial performance of the nasal drops is enhanced by antibacterial agents. At normal dosages, no obvious side effects will be produced, and no irritation or damage will be caused to the nasal mucosa. It can be used for a long time, and is especially suitable for special populations such as children, pregnant women and the elderly, and has a high safety of use.

[0043] Vitamin C is the core ingredient of this formula, and its content is determined based on a comprehensive consideration of the absorption capacity of the nasal mucosa and the therapeutic effect. When the concentration of vitamin C is within the above range, an effective drug concentration gradient can be formed on the surface of the nasal mucosa, stimulating nasal metabolism with a higher concentration of vitamin C. At the same time, the vitamin C solution can acidify the infected mucosa and dissolve the waste liquid and discharge it from the nasal cavity in the form of nasal mucus, thereby reducing the number of pathogens inside the nasal cavity and thereby improving the healing effect of nasal diseases. Different from traditional bactericidal and antibacterial methods, it can effectively avoid drug resistance problems. Even if too much vitamin C is absorbed by the human body, it will be excreted from the body through urine. Compared with oral vitamin C, the topical treatment effect is more prominent, which can significantly enhance the immunity of the nasal mucosa, strengthen the natural defense function of the respiratory tract, relieve nasal dryness and discomfort, and improve respiratory health.

[0044] Antibacterial agents can increase the bactericidal effect of the nasal drop system and effectively remove latent pathogens inside the nasal cavity. Moisturizers can keep the nasal cavity moist, prevent the nasal cavity from drying out, and effectively maintain the protective effect of the nasal mucosa. Stabilizers can prevent the oxidation of vitamin C in the nasal drops. Preservatives can prevent microbial contamination of the nasal drops. Osmotic pressure regulators make the osmotic pressure of the nasal drops match the physiological osmotic pressure of the human nasal mucosa, reduce the irritation of the nasal drops to the nasal mucosa, and improve the patient's comfort. pH regulators are used to adjust the pH value of the nasal drops to close to the normal pH value of the human nasal mucosa, which is beneficial to the stability of vitamin C and the absorption of drugs by the nasal mucosa.

[0045] In order to expand the audience of nasal drops, the mass concentration of vitamin C is adjusted to 25% to 33%, which can not only ensure that the vitamin C in the nasal drops still has a high concentration to work at room temperature, but also effectively avoid the precipitation phenomenon caused by excessive concentration of vitamin C in the nasal drops.

[0046] The mass concentration of the osmotic pressure regulator is 1% to 3%, and the osmotic pressure regulator includes sodium chloride and glucose, the antibacterial agent includes benzalkonium chloride, the humectant includes glycerol, the mass concentration of the stabilizer is 0.05% to 0.2%, and the stabilizer includes disodium EDTA, the mass concentration of the preservative is 0.05% to 0.2%, and the preservative includes benzoic acid, sorbic acid and parabens, the pH adjuster includes phosphate buffer and acetate buffer, and the added amount is an amount for adjusting the pH value of the nasal drop system to 5.5 to 7.5.

[0047] Embodiment three:

[0048] See also Figure 1 - Figure 2 As shown, a vitamin C nasal drop for removing latent pathogens comprises the following components: vitamin C, with a mass concentration of 20% to 40%; an osmotic pressure regulator, with a mass concentration of 0.5% to 5%; an antibacterial agent, with a mass concentration of 0.01% to 0.05%; a moisturizer, with a mass concentration of 1% to 3%; a stabilizer, with a mass concentration of 0.01% to 0.5%; a preservative, with a mass concentration of 0.01% to 0.5%; a pH regulator; and a purified water solvent.

[0049] As can be seen from the above, vitamin C nasal drops are composed of vitamin C, osmotic pressure regulators, antibacterial agents, moisturizers, stabilizers, preservatives, pH regulators and purified water solvents. Vitamin C has multiple physiological functions such as anti-oxidation, enhancing immunity, anti-inflammatory and promoting mucosal repair. It can comprehensively treat nasal diseases from multiple aspects, can significantly reduce the patient's nasal mucosal inflammation, help restore the integrity of mucosal epithelial cells, significantly improve nasal ventilation function, and effectively relieve symptoms such as nasal congestion, runny nose, sneezing, etc. The use of this nasal drop can stimulate the metabolism of the nasal cavity, and the nasal drop can acidify the infected mucosa and eliminate bacteria. The nasal drop waste liquid and infected mucosa are discharged together through secretions such as nasal mucus, and the bacteria inside the nasal cavity are discharged to form a nasal environment with few bacteria and safety. In addition, the antibacterial performance of the nasal drops is enhanced by antibacterial agents. At normal dosages, no obvious side effects will be produced, and no irritation or damage will be caused to the nasal mucosa. It can be used for a long time, and is especially suitable for special populations such as children, pregnant women and the elderly, and has a high safety of use.

[0050] Vitamin C is the core ingredient of this formula, and its content is determined based on a comprehensive consideration of the absorption capacity of the nasal mucosa and the therapeutic effect. When the concentration of vitamin C is within the above range, an effective drug concentration gradient can be formed on the surface of the nasal mucosa, stimulating nasal metabolism with a higher concentration of vitamin C. At the same time, the vitamin C solution can acidify the infected mucosa and dissolve the waste liquid and discharge it from the nasal cavity in the form of nasal mucus, thereby reducing the number of pathogens inside the nasal cavity and thereby improving the healing effect of nasal diseases. Different from traditional bactericidal and antibacterial methods, it can effectively avoid drug resistance problems. Even if too much vitamin C is absorbed by the human body, it will be excreted from the body through urine. Compared with oral vitamin C, the topical treatment effect is more prominent, which can significantly enhance the immunity of the nasal mucosa, strengthen the natural defense function of the respiratory tract, relieve nasal dryness and discomfort, and improve respiratory health.

[0051] Antibacterial agents can increase the bactericidal effect of the nasal drop system and effectively remove latent pathogens inside the nasal cavity. Moisturizers can keep the nasal cavity moist, prevent the nasal cavity from drying out, and effectively maintain the protective effect of the nasal mucosa. Stabilizers can prevent the oxidation of vitamin C in the nasal drops. Preservatives can prevent microbial contamination of the nasal drops. Osmotic pressure regulators make the osmotic pressure of the nasal drops match the physiological osmotic pressure of the human nasal mucosa, reduce the irritation of the nasal drops to the nasal mucosa, and improve the patient's comfort. pH regulators are used to adjust the pH value of the nasal drops to close to the normal pH value of the human nasal mucosa, which is beneficial to the stability of vitamin C and the absorption of drugs by the nasal mucosa.

[0052] In order to expand the audience of nasal drops, the mass concentration of vitamin C is adjusted to 25% to 33%, which can not only ensure that the vitamin C in the nasal drops still has a high concentration to work at room temperature, but also effectively avoid the precipitation phenomenon caused by excessive concentration of vitamin C in the nasal drops.

[0053] The mass concentration of the osmotic pressure regulator is 1% to 3%, and the osmotic pressure regulator includes sodium chloride and glucose, the antibacterial agent includes benzalkonium chloride, the humectant includes glycerol, the mass concentration of the stabilizer is 0.05% to 0.2%, and the stabilizer includes disodium EDTA, the mass concentration of the preservative is 0.05% to 0.2%, and the preservative includes benzoic acid, sorbic acid and parabens, the pH adjuster includes phosphate buffer and acetate buffer, and the added amount is an amount for adjusting the pH value of the nasal drop system to 5.5 to 7.5.

[0054] Reference Figure 2 The preparation method of vitamin C nasal drops is as follows:

[0055] Weigh and take the corresponding mass of vitamin C, osmotic pressure regulator, antibacterial agent, moisturizer, stabilizer, preservative, pH regulator and purified water solvent according to the configuration requirements;

[0056] Dissolve vitamin C in a portion of purified water solvent and stir until the vitamin C is completely dissolved to obtain a vitamin C solution;

[0057] Adding an osmotic pressure regulator, an antibacterial agent, a moisturizer, a stabilizer, a preservative and a pH regulator to the vitamin C solution in sequence, stirring until completely dissolved, to obtain a nasal drop concentrate;

[0058] Add the remaining purified water solvent to the nasal drops concentrate, and stir evenly to obtain the nasal drops;

[0059] The nasal drops were filtered through a 0.22 μm microporous filter membrane to obtain sterile nasal drops;

[0060] The sterile nasal drops are filled into a sterile nasal drops bottle, and sealed to obtain a finished nasal drops product.

[0061] To accelerate the dissolution rate of vitamin C, the stirring is performed until the vitamin C is completely dissolved so that the temperature is 40°C to 60°C.

[0062] Vitamin C nasal drops of the present invention are suitable for all kinds of nasal disease patients, such as acute rhinitis, chronic rhinitis, allergic rhinitis, sinusitis, etc. During use, the patient needs to clean the nasal cavity first, then take an appropriate amount of nasal drops, generally 2-3 drops per nostril each time, the head is slightly tilted back, the nasal drops are dripped into the nasal cavity, and the nose wing is gently pressed so that the liquid is fully distributed on the nasal mucosa surface. Use 3-4 times a day, or increase or decrease the number of times of use as appropriate according to the severity of the disease. After use, nasal drops stimulate nasal metabolism, promote the discharge of pathogens, and blow your nose after washing your face with hot water on the second day, and a large amount of thick nasal mucus can be excluded. These thick nasal mucus are the residual liquid of nasal drops and the infected mucosa of corruption. After the nasal mucus is discharged, the nasal environment can be effectively improved. Generally, obvious therapeutic effects can be observed in 1-2 weeks of continuous use, such as nasal congestion symptoms relief, nasal secretions reduction, sneezing number reduction, etc.

[0063] Vitamin C has multiple physiological functions such as anti-oxidation, enhancing immunity, anti-inflammatory and promoting mucosal repair, and can comprehensively treat nasal diseases from multiple aspects. Experimental studies have shown that after using the vitamin C nasal drops of the present invention, the patient's nasal mucosal inflammation is significantly reduced, the integrity of the mucosal epithelial cells is restored, the nasal ventilation function is significantly improved, and the symptoms such as nasal congestion, runny nose, and sneezing are effectively alleviated. The cure rate and effective rate are both high, and vitamin C, as a common raw material, has a relatively low market price, and the present invention has a simple formula, a simple preparation process, a low production cost, and a relatively close market price, which can benefit more patients and has a good market promotion prospect.

[0064] The nasal drops of the present invention are in liquid dosage form, and only need to be simply dripped into the nasal cavity when used, without complicated operation and equipment, and are easy for patients to accept and use, with good compliance. At the same time, the packaging design is reasonable, easy to carry and store, and can be used anytime and anywhere, which is conducive to patients adhering to treatment and improving treatment effects.

[0065] In the description of this specification, the description with reference to the terms "one embodiment", "some embodiments", "example", "specific example" or "some examples" etc. means that the specific features, structures, materials or characteristics described in conjunction with the embodiment or example are included in at least one embodiment or example of the present invention. In this specification, the schematic representations of the above terms do not necessarily refer to the same embodiment or example. Moreover, the specific features, structures, materials or characteristics described may be combined in any one or more embodiments or examples in a suitable manner. In addition, those skilled in the art may combine and combine the different embodiments or examples described in this specification and the features of the different embodiments or examples, unless they are contradictory.

[0066] In the drawings of the embodiments disclosed in the present invention, only the structures related to the embodiments disclosed in the present invention are involved, and other structures can refer to the general design. In the absence of conflict, the same embodiment and different embodiments of the present invention can be combined with each other.

Claims

1. A vitamin C nasal drop for removing latent pathogens, characterized in that: Includes the following components: Vitamin C, mass concentration is 20% to 40%; Osmotic pressure regulator, mass concentration is 0.5% to 5%; Antimicrobial agent, mass concentration is 0.01% to 0.05%; Moisturizer, mass concentration is 1% to 3%; Stabilizer, mass concentration is 0.01% to 0.5%; Preservatives, mass concentration is 0.01% to 0.5%; pH adjusters; Purified water solvent.

2. The vitamin C nasal drops for removing latent pathogens according to claim 1, characterized in that: The mass concentration of the vitamin C is 25% to 33%.

3. The vitamin C nasal drops for removing latent pathogens according to claim 1, characterized in that: The mass concentration of the osmotic pressure regulator is 1% to 3%, and the osmotic pressure regulator includes sodium chloride and glucose.

4. The vitamin C nasal drops for removing latent pathogens according to claim 1, characterized in that: The antimicrobial agent includes benzalkonium chloride.

5. The vitamin C nasal drops for removing latent pathogens according to claim 1, characterized in that: The humectant includes glycerin.

6. The vitamin C nasal drops for removing latent pathogens according to claim 1, characterized in that: The mass concentration of the stabilizer is 0.05% to 0.2%, and the stabilizer includes disodium EDTA.

7. The vitamin C nasal drops for removing latent pathogens according to claim 1, characterized in that: The mass concentration of the preservative is 0.05% to 0.2%, and the preservative includes benzoic acid, sorbic acid and p-hydroxybenzoic acid esters.

8. The vitamin C nasal drops for removing latent pathogens according to claim 1, characterized in that: The pH regulator includes phosphate buffer and acetate buffer, and the added amount is an amount to adjust the pH value of the nasal drop system to 5.5-7.

5.

9. The vitamin C nasal drops for removing latent pathogens according to claim 1, characterized in that: The preparation method of vitamin C nasal drops is as follows: Weigh and take the corresponding mass of vitamin C, osmotic pressure regulator, antibacterial agent, moisturizer, stabilizer, preservative, pH regulator and purified water solvent according to the configuration requirements; Dissolve vitamin C in a portion of purified water solvent and stir until the vitamin C is completely dissolved to obtain a vitamin C solution; Adding an osmotic pressure regulator, an antibacterial agent, a moisturizer, a stabilizer, a preservative and a pH regulator to the vitamin C solution in sequence, stirring until completely dissolved, to obtain a nasal drop concentrate; Add the remaining purified water solvent to the nasal drops concentrate, and stir evenly to obtain the nasal drops; The nasal drops were filtered through a 0.22 μm microporous filter membrane to obtain sterile nasal drops; The sterile nasal drops are filled into a sterile nasal drops bottle, and sealed to obtain a finished nasal drops product.

10. The vitamin C nasal drops for removing latent pathogens according to claim 9, characterized in that: The stirring is performed until the vitamin C is completely dissolved so that the temperature is 40°C to 60°C.